ImageneBio Inc
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a IMA research report →
Companywww.inmagenebio.com
Clinical-stage biotechnology company developing differentiated therapies for immunological/autoimmune & inflammatory (I&I) diseases, notably non‑depleting anti‑OX40 monoclonal antibody IMG‑007 in Phase 2b for atopic dermatitis
- CEO
- Kristin Yarema
- IPO
- 1998
- Employees
- 10
- HQ
- San Diego, CA, US
Price Chart
Valuation
- Market Cap
- $61.02M
- P/E
- -1.35
- P/S
- 0.00
- P/B
- 0.49
- EV/EBITDA
- 0.13
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -35.20%
- ROIC
- -41.95%
Growth & Income
- Revenue
- $800.00K · -77.14%
- Net Income
- $-45,349,000 · -24.01%
- EPS
- $-10.76 · -954.90%
- Op Income
- $-48,451,000
- FCF YoY
- -4.00%
Performance & Tape
- 52W High
- $18.00
- 52W Low
- $3.94
- 50D MA
- $5.60
- 200D MA
- $7.69
- Beta
- 0.74
- Avg Volume
- 360.17K
Get TickerSpark's AI analysis on IMA
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 20, 26 | Lally Robert B | other | 0 |
| Mar 20, 26 | Lally Robert B | other | 25,410 |
| Apr 16, 26 | Su Wei-guo | other | 0 |
| Apr 14, 26 | Bonita David P | buy | 384,689 |
| Apr 14, 26 | Bonita David P | buy | 336,603 |
| Apr 14, 26 | ORBIMED ADVISORS LLC | buy | 384,689 |
| Apr 14, 26 | ORBIMED ADVISORS LLC | buy | 336,603 |
| Mar 16, 26 | Yarema Kristin | other | 128,100 |
| Mar 16, 26 | Yarema Kristin | other | 85,400 |
| Feb 16, 26 | Porter-Brown Benjamin | other | 0 |
Our IMA Coverage
We haven't published any research on IMA yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate IMA Report →